Bio Conscious Technologies Integrates GPT-4 into Endobits V5 for Enhanced Diabetes Care

Bio Conscious Technologies Inc., known for its innovations at the intersection of Artificial Intelligence (AI) and Health Technology, has integrated GPT 4 LLM into its Endobits platform. This integration aims to bolster the quality and efficiency of diabetes care by utilizing the latest in machine learning capabilities to analyze patient glucose data and provide recommendations based on American Diabetes Association guidelines.

With diabetes on the rise globally, expected to affect 700 million by 2045, the demand for effective management tools is increasing. Endobits V5, an Automated Remote Patient Management software, now supports healthcare professionals by generating comprehensive patient chart notes, offering care recommendations, and highlighting key patient issues that may require attention. This capability helps in reducing the time spent on administrative tasks and focuses on patient-centered care.

Amir Hayeri, CEO of Bio Conscious, emphasized the reduction in the burden of note-taking and billing, enhancing the care delivery by healthcare providers. Dr. Jerome Fischer, Chief Medical Officer, also highlighted the system's ability to provide more personalized and proactive healthcare solutions, improving outcomes for patients with diabetes.